The overall objective of this project is to develop and validate statistical and systems biology-based patient stratification tools for the personalised treatment of melanoma patients. As part of the EU FP7 SYS-MEL consortium, the candidate will be responsible for the analysis of clinicopathological patient data and quantitative protein data, such as key players of epigenetic expression control and apoptosis regulation.
Excellent communication skills and the ability and willingness to operate at the interface of multiple, traditionally separated disciplines is a key requirement for this position. The successful candidate will receive a competitive Marie S. Curie Experienced Researcher living and mobility allowance.
The position is available initially for 1 year, with the possibility for extension.
Current application deadline: 30 June, 2016
More information available here